ClinConnect ClinConnect Logo
Search / Trial NCT06765083

Can We 'hear' Femoral Neck Fractures? Ultrasound Guided Diagnosis of Femoral Neck Fractures

Launched by MEDICAL CENTRE LEEUWARDEN · Jan 2, 2025

Trial Information

Current as of May 01, 2025

Not yet recruiting

Keywords

Femoral Neck Pertrochanteric Hip Fracture Pocus Ultrasound Diagnostic Emergency Department Proximal Femur

ClinConnect Summary

This clinical trial is exploring a new way to diagnose hip fractures, specifically femoral neck and intertrochanteric fractures, using a method called point-of-care ultrasound (POCUS). This technique is being compared to traditional X-rays, which are the current standard. The hope is that POCUS, which is portable, cost-effective, and uses no radiation, can provide faster and more accurate diagnoses right in the emergency department. This could also help reduce waiting times for pain relief and ease overcrowding in emergency rooms, especially in places where X-ray machines are not available.

To participate in this trial, you need to be at least 18 years old and have a painful hip after a recent injury that makes your doctor suspect a hip fracture. However, if you've had previous hip surgeries, certain injuries, or if you have trouble understanding the consent process, you may not be eligible. If you join the study, you can expect to undergo the ultrasound assessment for your hip and possibly help improve future diagnosis and treatment for others with similar injuries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ≥18 years of age
  • presenting to the ED with a painful hip after trauma, suspected of hip fracture as defined by the attending clinician
  • Exclusion Criteria:
  • History of hip fracture or surgical procedure on the bones of the ipsilateral hip (ultrasound images may be unreliable)
  • Presence of foreign body material in the ipsilateral hip
  • Skin defects at the POCUS site e.g. lacerations, infected skin
  • Extensive injuries, extreme pain or neurovascular damage where urgent intervention is required
  • Inability to give informed consent (cognitive impairments, no proficient understanding of the Dutch or English language)

About Medical Centre Leeuwarden

Medical Centre Leeuwarden is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a multidisciplinary team of experienced healthcare professionals, the centre focuses on a wide range of therapeutic areas, leveraging state-of-the-art facilities and cutting-edge technology. Committed to ethical standards and patient safety, Medical Centre Leeuwarden collaborates with academic institutions and industry partners to contribute to the development of new treatments and therapies, ensuring that the latest advancements in medicine are translated into effective healthcare solutions for the community.

Locations

Leeuwarden, , Netherlands

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported